LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Trial Profile

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary)
  • Indications Plaque psoriasis
  • Focus Registrational; Therapeutic Use
  • Acronyms PSO-LONG
  • Sponsors LEO Pharma
  • Most Recent Events

    • 22 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 15 Dec 2016 Planned End Date changed from 1 Sep 2018 to 1 Feb 2019.
    • 15 Dec 2016 Planned primary completion date changed from 1 Aug 2018 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top